BIZTRAC BETA
Retail sale of pharmaceutical products

APOMED AS

Org. no. 924957034 Limited company (AS) Oslo Incorporated 2020 Active
Ownership graph ↗
Revenue 2024 NOK 15.2m
Operating profit NOK −20.3m
Equity NOK −15.2m
Incorporated 2020
Employees 10
Share capital NOK 1.0m

Signals

2 flags
  • Negativ egenkapital 2024 Bokført egenkapital er negativ (−15,2 mill kr).
  • Driftsunderskudd 2024 Siste driftsresultat er negativt (−20,3 mill kr).

APOMED AS is registered as a limited company in Oslo, Oslo with organisation number 924957034. The business is classified under retail sale of pharmaceutical products (NACE 47.730). The company was incorporated in 2020 and has 10 registered employees. Registered share capital is NOK 1.0m, divided into 1002000 shares. The company's stated purpose is: “Salg av apotekvarer og tilhørende varer og tjenester, samt eierskap i andre selskap, og alt som hører dertil.”. The most recent filed accounts, for the 2024 financial year, show NOK 15.2m in revenue and NOK −20.3m in operating profit.

Key figures · 2024

Revenue
NOK 15.2m
Operating profit
NOK −20.3m
Equity
NOK −15.2m

Financial health · 2024

Liquidity
0.34
Not satisfactory
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
-328.7%
Weak
Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns APOMED AS?

APOMED HOLDING AS
APOMED AS
NOK 15.2m rev. · NOK −20.3m profit

APOMED AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about APOMED AS

Who owns APOMED AS?

APOMED HOLDING AS is the largest registered owner, with 100.0%.

What is the revenue of APOMED AS?

APOMED AS had revenue of NOK 15.2m in 2024.

Where is APOMED AS based?

APOMED AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.